We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

How Does an Antibody Become a PrecisionAb™ Antibody?

Video   Nov 24, 2017

 

For more information, visit http://www.bio-rad.com/CheckoutPrecis... For a primary antibody to be selected as a PrecisionAb Antibody, it must be highly specific, highly sensitive, and pass a rigorous validation process that includes consistent performance from batch to batch. Out of throusands of primary antibodies screened, only a few are admitted into the elite PrecisionAb Antibody category. Try PrecisionAb Antibodies and see how you can generate reproducible data without wasting time and resources on optimization. PrecisionAb Validated Western Blotting Antibodies offer researchers • High specificity and sensitivity – selected for low nonspecific binding, correct target molecular weight, and the strongest signal on a western blot • Reproducible results – stringent QC requirements ensure consistent lot-to-lot performance • Trial size for every antibody (2 applications) - conveniently evaluate western blot performance • Confidence in your data – positive control lysate provided for each antibody; validation protocol included We Are Bio-Rad. Our mission: To provide useful, high-quality products and services that advance scientific discovery and improve healthcare. At Bio-Rad, we are united behind this effort. These two objectives are the driving force behind every decision we make, from developing innovative ideas to building global solutions that help solve our customers' greatest challenges. Connect with Bio-Rad Antibodies Online: Website: https://www.bio-rad-antibodies.com/ LinkedIn: https://www.linkedin.com/showcase/bio... Facebook: https://www.facebook.com/BioRadAntibo... Twitter: https://twitter.com/BioRadAbs Pinterest: https://www.pinterest.com/BioRadAbs/ Instagram: @BioRadLabs Snapchat: @BioRadLabs


 
More Information

Request Information

 
 
 

Recommended Videos

Breast Density: A Personal Biomarker of Cancer

Video

Diminishing fear and inspiring curiosity – using medical transparency to educate on breast health.

WATCH NOW

Biomarker-based Companion Diagnostics Are Enabling Precision Oncology

Video

Clinical trials are underway to examine the efficacy of various immune checkpoint inhibitor molecules, for the treatment of cancer. Watch this video to learn about the companion diagnostics that are enabling the identification of patients who could benefit from these treatments.

WATCH NOW

Sanger Institute - UK Biobank Whole Genome Sequencing Project

Video

The genetic code of all 500,000 UK Biobank volunteer participants will be sequenced by researchers at the Wellcome Sanger Institute in the UK and deCODE genetics in Iceland. This project is the single most ambitious sequencing programme in the world undertaken by a public-private partnership, and will power the next wave of genetic and health research

WATCH NOW

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE